LAVAL, Canada--(BUSINESS WIRE)--Dec. 23, 2005--In accordance with its continuous disclosure obligations, BioSyntech, Inc. (TSX VENTURE:BSY) announces the grant of options to acquire 15,000 common shares of its capital stock at a price of $0.69 per share for a period of five years to each of its four independent directors, namely: Mr. Joseph Benarrosh, Mr. Christophe Guy, Mr. Somesh Sharma and Mr. Serge Savard. Furthermore, Mr. Joseph Benarrosh has been granted options to acquire 15,000 additional shares on the same terms and conditions in his capacity as Chairman of the Company’s Audit Committee.
